Leigh MacMillan

July 18, 2019

Madhur receives Presidential Early Career Award

Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers.

By Leigh MacMillan
July 8, 2019

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

By Leigh MacMillan
June 24, 2019

Early detection of schizophrenia

Inhibited temperament — a tendency to respond to novelty with wariness, fear or caution — may be a risk factor for schizophrenia that could be targeted for preventative interventions.

By Leigh MacMillan
June 24, 2019

Fish oil and cancer prevention

Fish oil supplementation provides a modest but beneficial effect on reducing molecules associated with colorectal cancer development.

By Leigh MacMillan
June 10, 2019

Cell-cell signals in developing heart

Scott Baldwin and colleagues have discovered early signaling events during heart development, findings that could guide cell replacement therapies for heart disease.

By Leigh MacMillan
June 6, 2019

Mouth microbes and colorectal cancer

Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC.

By Leigh MacMillan
May 29, 2019

Study details regulation of a multi-drug transporter

P-glycoprotein distinguishes between chemicals that it will expel from a cell and inhibitors that block its action.
By Leigh MacMillan
May 16, 2019

Byndloss selected for NIH future research leaders conference

Mariana Byndloss, DVM, PhD, has been selected to participate in the Future Research Leaders Conference at the National Institutes of Health.
By Leigh MacMillan
May 9, 2019

Frog fungus fights back

Louise Rollins-Smith and colleagues are exploring how a deadly fungus counters the amphibian immune response and contributes to declining worldwide amphibian populations.
By Leigh MacMillan
April 25, 2019

A new antibiotic’s mechanism of action

Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.
By Leigh MacMillan
April 25, 2019

Low oxygen and antibody responses

Mark Boothby and colleagues are exploring the factors that contribute to antibody production and quality, which are key to our defense against pathogens and response to vaccines.
By Leigh MacMillan
April 25, 2019

Salk Institute’s Hunter set for May 2 Discovery Lecture

Tony Hunter, PhD, an internationally recognized leader in the study of cell growth control, will deliver the final spring Flexner Discovery Lecture on Thursday, May 2.
By Leigh MacMillan
1 … 32 33 34 35 36 … 80